Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
2.440
+0.150 (6.55%)
Aug 21, 2026, 4:00 PM EDT - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $31.09 million as of August 21, 2026. Its market cap has decreased by -16.62% in one year.
Market Cap
31.09M
Enterprise Value
5.03M
1-Year Change
-16.62%
Ranking
Category
Stock Price
$2.44
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $31.09M, a decrease of -57.32%. That is a compound annual growth rate of -16.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 31.09M | -47.39% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lite Strategy | 33.67M |
| Quince Therapeutics | 33.18M |
| Estrella Immunopharma | 31.98M |
| IGC Pharma | 31.84M |
| Kyntra Bio | 30.45M |
| Actuate Therapeutics | 30.39M |
| NanoViricides | 30.30M |
| Lantern Pharma | 29.91M |